| Application no. and date | 16753390.0 (espacenet) (Federated) (European Patent Register), 20160818 | | Patent/reg. no. and date | DK/EP 3337801, 20190612 | | Publication date | 20180627 | | Priority no. and date | EP 15182042, 20150821, EP 15182040, 20150821 | | EP pub. no. and date |
EP 3337801 20180627 | | Effective date | | | Applicant/owner | Bayer Pharma Aktiengesellschaft, Müllerstrasse 178
13353 Berlin, DE | | Applicant ref. no. | 1507070 | | Inventor | PLATZEK, Johannes, Grottkauer Strasse 55
12621 Berlin, DE,
Lolli, Giulio, Holzweg 15
51069 Köln, DE,
GOTTFRIED, Kathrin, Nesselbergstrasse 25
42349 Wuppertal, DE,
ASSMANN, Jens, Steinkulle 16a
42781 Haan, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 471/04 (2006.01) , C25B 15/08 (2006.01) , C25B 3/02 (2006.01) , C25B 3/04 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOX AMID OG GENINDVINDING AF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOX.... | | Int. application no. | EP2016069567 | | Int. publication no. | WO2017032678 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
